Home
About
Overview
Sharing Data
ORCID
Help
History (18)
Lie Detection
Caveolin 3
Clinical symptoms and risk factors in cerebral microangiopathy patients.
Toyota v. Williams: determining disability under the ADA.
Lipopolysaccharide antagonists.
See All 18 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Lipopolysaccharide antagonists.
Lynn WA, Golenbock DT. Lipopolysaccharide antagonists. Immunol Today. 1992 Jul; 13(7):271-6.
View in:
PubMed
subject areas
Antimicrobial Cationic Peptides
Blood Proteins
Cytokines
Endotoxins
Gram-Negative Bacterial Infections
Humans
Lipid A
Lipopolysaccharides
Lymphocyte Activation
Membrane Proteins
Polymyxin B
Receptors, Immunologic
authors with profiles
Douglas T Golenbock MD